The cancer-testis antigen FBXO39 predicts poor prognosis and is associated with stemness and aggressiveness in glioma.
Wu J, Yao F, Li Y, Zhao Z, Liu J, Xu T, Chai J, Yang Y, Song J, Tian C, et al. Pathol Res Pract. 2022 Nov; 239:154168. Epub 2022 Oct 13.